Perceived treatability is not evidence of diagnostic validity and benefit: A response to Hastings and Hahn on borderline personality disorder
Hastings and Hahn report that a borderline personality disorder (BPD) label can improve selected treatment beliefs among clinical psychology trainees. However, more favourable clinician expectations should not be interpreted as evidence that receiving the diagnosis benefits patients. Perceived treatability, treatment efficacy, treatment safety, and patient benefit are distinct constructs. This distinction is particularly important given documented negative effects associated with dialectical behaviour therapy and broader limitations in the systematic assessment and reporting of treatment-related harm in psychotherapy research. Hastings and Hahn's vignette design also presupposes rather than evaluates the legitimacy of the BPD construct and cannot address diagnostic bias, harms arising from classification, or the lived consequences of diagnosis and subsequent care. Their findings therefore demonstrate a change in selected clinician beliefs, not improved care or net patient benefit. Claims of diagnostic benefit require evidence addressing treatment safety, patient-defined outcomes, diagnostic validity and bias, and lived experience.
Authors
- Charlotte Huggett (ORCID: https://orcid.org/0000-0002-7566-6224)
Publication Details
- Journal
- PsyArXiv (OSF Preprints)
- Published
- 2026-11-14
- DOI
- https://doi.org/10.31234/osf.io/ab3hf
- Primary Topic
- Personality Disorders and Psychopathology
- Type
- preprint